Chen J, Zhu Y, Qian G, Wang J, Lu J, Kensler T
Toxins (Basel). 2025; 17(2).
PMID: 39998096
PMC: 11860843.
DOI: 10.3390/toxins17020079.
Samanta S, Sarkar S, Kayal K
MethodsX. 2024; 13:102895.
PMID: 39687596
PMC: 11647952.
DOI: 10.1016/j.mex.2024.102895.
Sallah S, Warwicker J
PLoS One. 2024; 19(11):e0314022.
PMID: 39561123
PMC: 11575792.
DOI: 10.1371/journal.pone.0314022.
Dasgupta S, Gao S, Yang H, Greenberg M, Basu A
Chem Res Toxicol. 2024; 37(8):1445-1452.
PMID: 39041427
PMC: 11333159.
DOI: 10.1021/acs.chemrestox.4c00231.
Cordani M, Garufi A, Benedetti R, Tafani M, Aventaggiato M, DOrazi G
Biomolecules. 2024; 14(6).
PMID: 38927053
PMC: 11201733.
DOI: 10.3390/biom14060649.
How MicroRNAs Command the Battle against Cancer.
Wu H, Leng S, Sergi C, Leng R
Int J Mol Sci. 2024; 25(11).
PMID: 38892054
PMC: 11172831.
DOI: 10.3390/ijms25115865.
Mutant p53 reactivation restricts the protumorigenic consequences of wild type p53 loss of heterozygosity in Li-Fraumeni syndrome patient-derived fibroblasts.
Agarwal H, Tal P, Goldfinger N, Chattopadhyay E, Malkin D, Rotter V
Cell Death Differ. 2024; 31(7):855-867.
PMID: 38745079
PMC: 11239894.
DOI: 10.1038/s41418-024-01307-4.
Advancements in elucidating the pathogenesis of actinic keratosis: present state and future prospects.
Wang Z, Wang X, Shi Y, Wu S, Ding Y, Yao G
Front Med (Lausanne). 2024; 11:1330491.
PMID: 38566927
PMC: 10985158.
DOI: 10.3389/fmed.2024.1330491.
STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.
Somatilaka B, Madana L, Sadek A, Chen Z, Chandrasekaran S, McKay R
J Clin Invest. 2024; 134(10).
PMID: 38502231
PMC: 11093615.
DOI: 10.1172/JCI176748.
Study of biomarkers p53, Ki-67, Bcl-2, and VEGF in pterygium.
Ghosh S, Arora R, Hariani A, Saran R, Jain P
Indian J Ophthalmol. 2024; 72(Suppl 3):S448-S452.
PMID: 38324633
PMC: 467017.
DOI: 10.4103/IJO.IJO_2148_23.
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System.
Pateras I, Igea A, Nikas I, Leventakou D, Koufopoulos N, Ieronimaki A
Int J Mol Sci. 2024; 25(2).
PMID: 38279253
PMC: 10816510.
DOI: 10.3390/ijms25021251.
Methylenetetrahydrofolate Reductase C677T (rs1801133) Polymorphism Is Associated with Bladder Cancer in Asian Population: Epigenetic Meta-Analysis as Precision Medicine Approach.
Purnomo A, Daryanto B, Seputra K, Budaya T, Lutfiana N, Nurkolis F
Cancers (Basel). 2023; 15(17).
PMID: 37686678
PMC: 10487222.
DOI: 10.3390/cancers15174402.
Cannabidiol-induced crosstalk of apoptosis and macroautophagy in colorectal cancer cells involves p53 and Hsp70.
Wang F, Bashiri Dezfouli A, Khosravi M, Sievert W, Stangl S, Schwab M
Cell Death Discov. 2023; 9(1):286.
PMID: 37542074
PMC: 10403543.
DOI: 10.1038/s41420-023-01578-9.
Role of p53 suppression in the pathogenesis of hepatocellular carcinoma.
Choudhary H, Mandlik S, Mandlik D
World J Gastrointest Pathophysiol. 2023; 14(3):46-70.
PMID: 37304923
PMC: 10251250.
DOI: 10.4291/wjgp.v14.i3.46.
Unraveling the Role of Epithelial-Mesenchymal Transition in Adenoid Cystic Carcinoma of the Salivary Glands: A Comprehensive Review.
Hoch C, Stogbauer F, Wollenberg B
Cancers (Basel). 2023; 15(11).
PMID: 37296849
PMC: 10252036.
DOI: 10.3390/cancers15112886.
Design, Synthesis and Antitumor Activity of 1-indazole-3-amine Derivatives.
Wang C, Zhu M, Long X, Wang Q, Wang Z, Ouyang G
Int J Mol Sci. 2023; 24(10).
PMID: 37240028
PMC: 10218234.
DOI: 10.3390/ijms24108686.
GADD34 activates p53 and may have utility as a marker of atherosclerosis.
Tomiyoshi G, Nakamura R, Shinmen N, Yoshida Y, Mine S, Machida T
Front Med (Lausanne). 2023; 10:1128921.
PMID: 37228401
PMC: 10203227.
DOI: 10.3389/fmed.2023.1128921.
Progress toward Better Treatment of Therapy-Related AML.
Kotsiafti A, Giannakas K, Christoforou P, Liapis K
Cancers (Basel). 2023; 15(6).
PMID: 36980546
PMC: 10046015.
DOI: 10.3390/cancers15061658.
Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program.
Kalmar A, Galamb O, Szabo G, Pipek O, Medgyes-Horvath A, Bartak B
Cancers (Basel). 2023; 15(3).
PMID: 36765865
PMC: 9913259.
DOI: 10.3390/cancers15030907.
Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium.
Polverini P, Nor F, Nor J
Front Oral Health. 2023; 3:1095842.
PMID: 36704239
PMC: 9872128.
DOI: 10.3389/froh.2022.1095842.
